BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSLT
3776
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $22.1K | ﹤0.01% |
15,670
+4,345
| +38% | +$8.66K |
|
3777
Lands' End
LE
$391M
| $22.1K | ﹤0.01% |
1,945
-830
| -30% | -$8.76K |
|
3778
Global Water Resources
GWRS
$219M
| $22K | ﹤0.01% |
1,862
+567
| +44% | +$6.69K |
|
|
FRTA
3779
DELISTED
Forterra, Inc
FRTA
| $22K | ﹤0.01% |
3,047
+766
| +34% | +$4.94K |
|
|
AD
3780
Array Digital Infrastructure
AD
$3.04B
| $21.9K | ﹤0.01% |
584
-158
| -21% | -$6.38K |
|
|
RYZ
3781
Ryerson Holding Corp
RYZ
$1.5B
| $21.9K | ﹤0.01% |
2,569
-505
| -16% | -$3.97K |
|
3782
Talphera
TLPH
$72.7M
| $21.9K | ﹤0.01% |
+498
| New | +$24.5K |
|
3783
OptimizeRx
OPRX
$132M
| $21.9K | ﹤0.01% |
1,513
+1,482
| +4,781% | +$22.9K |
|
3784
Clearfield
CLFD
$395M
| $21.9K | ﹤0.01% |
1,845
+505
| +38% | +$6.18K |
|
3785
AXT Inc
AXTI
$5.13B
| $21.9K | ﹤0.01% |
6,139
-26
| -0.4% | -$100 |
|
3786
Scholar Rock
SRRK
$6.55B
| $21.8K | ﹤0.01% |
2,441
+687
| +39% | +$8.21K |
|
|
ZEUS
3787
DELISTED
Olympic Steel
ZEUS
| $21.8K | ﹤0.01% |
1,513
-10
| -0.7% | -$124 |
|
3788
Titan International
TWI
$450M
| $21.8K | ﹤0.01% |
8,068
-204
| -2% | -$671 |
|
3789
PUT
Allstate
ALL
$64.7B
| $21.7K | ﹤0.01% |
2
| – | – |
|
3790
Solid Biosciences
SLDB
$972M
| $21.7K | ﹤0.01% |
140
+50
| +56% | +$5.66K |
|
3791
Ascent Industries
ACNT
$133M
| $21.7K | ﹤0.01% |
1,358
+16
| +1% | +$256 |
|
3792
KB Financial Group
KB
$41.4B
| $21.6K | ﹤0.01% |
606
+389
| +179% | +$13.7K |
|
3793
Grocery Outlet
GO
$1.01B
| $21.6K | ﹤0.01% |
+622
| New | +$23.6K |
|
|
CALA
3794
DELISTED
Calithera Biosciences, Inc
CALA
| $21.5K | ﹤0.01% |
348
+92
| +36% | +$7.37K |
|
3795
Boston Omaha
BOC
$436M
| $21.4K | ﹤0.01% |
1,079
+303
| +39% | +$6.46K |
|
|
FARM
3796
DELISTED
Farmer Brothers
FARM
| $21.4K | ﹤0.01% |
1,652
-41
| -2% | -$592 |
|
|
GPP
3797
DELISTED
Green Plains Partners LP
GPP
| $21.2K | ﹤0.01% |
1,597
-1,131
| -41% | -$15.3K |
|
3798
Seres Therapeutics
MCRB
$47.4M
| $21.2K | ﹤0.01% |
264
+146
| +124% | +$9.65K |
|
3799
EVI Industries
EVI
$206M
| $21.2K | ﹤0.01% |
663
+222
| +50% | +$7.37K |
|
|
GCAP
3800
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $21.1K | ﹤0.01% |
3,989
+41
| +1% | +$192 |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.